InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,042.91
(
-0.57%
)
US TECH 100
16,902.80
(
-0.92%
)
Dow Jones
38,099.01
(
-0.94%
)
Brent Oil
87.26
(
0.05%
)
Bitcoin
64,527.40
(
0.38%
)
Post# of 1665
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

pivotpoint1

Send PM Follow Ignore
Followers 281
Posts 59167
Boards Moderated 0
Alias Born 02/15/2012

pivotpoint1

Re: None

Tuesday, 02/16/2016 11:30:42 AM

Tuesday, February 16, 2016 11:30:42 AM

Post# of 1665
OBMP ~ The presentation will include a corporate overview that includes the latest data from the ongoing Phase 1 clinical trial of ProscaVax for prostate cancer; information on the Phase 2 trial of ProscaVax planned for the first half of 2016; and other clinical and business developments.

Sign up for OncBioMune email alerts at: http://oncbiomune.com/email-alerts/.

http://finance.yahoo.com/news/oncbiomune-invites-shareholders-join-live-100000240.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up